GMM Pfaudler Limited has announced the appointment of Mr. Ankit Nayyar as its new Group Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). Nayyar’s appointment is effective from November 4, 2026, following the conclusion of the Q2 FY27 Board Meeting. This follows the resignation of the current CFO, Mr. Alexander Poempner, who will continue until December 31, 2026, to ensure a smooth transition.
GMM Pfaudler Announces Leadership Change in Finance
GMM Pfaudler Limited has officially announced a significant change in its top financial leadership. The Board of Directors, during its meeting held on September 15, 2026, approved the appointment of Mr. Ankit Nayyar as the new Group Chief Financial Officer (CFO) and Key Managerial Personnel (KMP).
Key Appointment Details
Mr. Nayyar’s appointment will take effect on November 4, 2026, concurrent with the conclusion of the board meeting that will approve the unaudited financial results for the second quarter and half year ended September 30, 2026 (Q2 FY27). The company highlighted Mr. Nayyar’s extensive experience, with nearly two decades in pharmaceuticals, specialty chemicals, manufacturing, and financial services. Previously, he served as Deputy CFO starting in May 2026 and held significant roles at PI Health Sciences, Monsanto, and Bayer.
Outgoing CFO’s Transition
The announcement also acknowledged the resignation of the current Group CFO, Mr. Alexander Poempner. His resignation is effective at the conclusion of the Q2 FY27 Board Meeting on November 4, 2026. However, Mr. Poempner has committed to remaining with the organization until December 31, 2026, to facilitate an orderly handover and provide essential transition support.
Appreciation for Past Contributions
The Board of Directors expressed its sincere appreciation for Mr. Poempner’s leadership, dedication, and contributions during his tenure with GMM Pfaudler Limited, wishing him the best in his future endeavors.
Source: BSE
